Unspecified B-cell lymphoma, intra-abdominal lymph nodes is a type of non-Hodgkin lymphoma characterized by the proliferation of B-lymphocytes in the intra-abdominal lymph nodes. This condition can lead to significant morbidity and requires accurate diagnosis and documentation for effective treatment and management. The ICD-10 Code C85.13 facilitates precise coding for billing, clinical decision-making, and public health reporting, ensuring that healthcare providers can track and manage this condition effectively.
ICD-10 Code C85.13 represents Unspecified B-cell lymphoma affecting the intra-abdominal lymph nodes. This code is utilized when a definitive subtype of B-cell lymphoma has not been identified, yet the clinical presentation suggests lymphomatous involvement of intra-abdominal lymphatic tissue. It is essential for accurate clinical documentation and billing, particularly in cases where further diagnostic clarification is pending.
Unspecified B-cell lymphoma, intra-abdominal lymph nodes is a hematological malignancy that arises from B-lymphocytes, often presenting with lymphadenopathy and systemic symptoms. The etiology may involve genetic mutations or environmental factors, and the disease can progress rapidly, necessitating prompt medical intervention.
In clinical workflows, ICD-10 Code C85.13 is integral for documenting patient assessments, treatment plans, and outcomes. It aids in capturing the complexity of the patient's condition, ensuring comprehensive care in both acute and chronic settings.
ICD-10 Code C85.13 connects subjective patient reports and objective clinical findings to a formal diagnosis of unspecified B-cell lymphoma affecting intra-abdominal lymph nodes. This code is crucial for maintaining continuity of care, supporting accurate billing, and meeting EHR documentation standards.
Management of Unspecified B-cell lymphoma, intra-abdominal lymph nodes often requires hospitalization for intensive treatment. Chemotherapy is the primary treatment modality, and supportive care is essential to manage symptoms and complications.


HIPAA-compliant and designed with privacy in mind, your patient’s data is protected. Focus on care while we safeguard your information.
Learn moreICD-10 Code C85.13 is crucial for accurate billing in hospital, ER, or infectious disease care settings, ensuring appropriate reimbursement for services rendered.
| CPT Code | Description |
|---|---|
| 85025 | Complete blood count (CBC) with automated differential. |
| 88305 | Pathology examination of tissue for lymphoma diagnosis. |
| 96413 | Chemotherapy administration, intravenous, for lymphoma treatment. |
| 77014 | Radiologic guidance for needle placement in lymph node biopsy. |
Common Questions About Using ICD-10 Code C85.13 for Unspecified B-cell lymphoma, intra-abdominal lymph nodes
What are the common symptoms of Unspecified B-cell lymphoma?
Common symptoms include abdominal pain, unexplained weight loss, night sweats, and fatigue. Patients may also experience lymphadenopathy, which can be detected during physical examinations or imaging studies.
How is Unspecified B-cell lymphoma diagnosed?
Diagnosis typically involves imaging studies such as CT scans, blood tests to assess tumor markers, and biopsy of affected lymph nodes to confirm the presence of lymphoma cells.
What treatment options are available for this condition?
Treatment usually includes chemotherapy, which may be combined with targeted therapies. Supportive care is also essential to manage symptoms and improve the patient's quality of life.
Is hospitalization required for patients with this diagnosis?
Yes, hospitalization is often necessary for patients with Unspecified B-cell lymphoma, especially during the initiation of chemotherapy or if complications arise.
Clinical Notes
SOAP notes
DAP notes
AI medical notes